Unknown

Dataset Information

0

New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies.

ABSTRACT: Fifteen quinazoline derivatives were designed and synthesized as DNA intercalators. The cytotoxicity of the designed members was assessed against HCT-116 and HepG2 cancer cell lines. In addition, the topoisomerase II (Topo II) inhibitory effect was assessed. Compound 16 was the most cytotoxic and Topo II inhibitor with low cytotoxicity against Vero cells. Compounds 16, 17, and 18 showed significant DNA binding affinities. Compound 16 showed Topo II catalytic inhibitory effect at a concentration of 10 μM. Further mechanistic investigations revealed the capability of compound 16 to induce apoptosis in HCT-116 cells and arrest the growth at the S and G2/M phases. Also, compound 16 showed a significant increase in the level of BAX (2.18-fold) and a marked decrease in the level of Bcl-2 (1.9-fold) compared to the control cells. In silico studies revealed the ability of the synthesized members to bind to the DNA-Topo II complex.

SUBMITTER: Gaber AA 

PROVIDER: S-EPMC9886266 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies.

Gaber Ahmed A AA   Sobhy Mohamed M   Turky Abdallah A   Eldehna Wagdy M WM   El-Sebaey Samiha A SA   El-Metwally Souad A SA   El-Naggar Abeer M AM   Ibrahim Ibrahim M IM   Elkaeed Eslam B EB   Metwaly Ahmed M AM   Eissa Ibrahim H IH  

PloS one 20230130 1

Fifteen quinazoline derivatives were designed and synthesized as DNA intercalators. The cytotoxicity of the designed members was assessed against HCT-116 and HepG2 cancer cell lines. In addition, the topoisomerase II (Topo II) inhibitory effect was assessed. Compound 16 was the most cytotoxic and Topo II inhibitor with low cytotoxicity against Vero cells. Compounds 16, 17, and 18 showed significant DNA binding affinities. Compound 16 showed Topo II catalytic inhibitory effect at a concentration  ...[more]

Similar Datasets

Unknown Synthesis, biological activity and molecular modeling study of novel 1,2,4-triazolo[4,3-b][1,2,4,5]tetrazines and 1,2,4-triazolo[4,3-b][1,2,4]triazines.
| S-EPMC7145827 | biostudies-literature
Unknown [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
| S-EPMC3906316 | biostudies-literature
Unknown 3-Aryl-5-aminobiphenyl Substituted [1,2,4]triazolo[4,3-<i>c</i>]quinazolines: Synthesis and Photophysical Properties.
| S-EPMC9963873 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-<i>a</i>] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors.
| S-EPMC9019572 | biostudies-literature
Unknown Synthesis and Reactivity of [1,2,4]Triazolo-annelated Quinazolines
| S-EPMC6259257 | biostudies-literature
Unknown Pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines as Selective, Brain Penetrant Phosphodiesterase 2 (PDE2) Inhibitors.
| S-EPMC4360147 | biostudies-literature
Unknown 6-Methyl-7,7,9-tripropargyl-7H-1,2,4-triazolo[4,3-b][1,2,4]triazepin-8(9H)-one.
| S-EPMC2969890 | biostudies-literature
Unknown 7,9-Diallyl-6-methyl-7H-1,2,4-triazolo[4,3-b][1,2,4]triazepin-8(9H)-one.
| S-EPMC2969987 | biostudies-literature
Unknown Design, Synthesis, and Antifungal Activity of Novel 1,2,4-Triazolo[4,3-c]trifluoromethylpyrimidine Derivatives Bearing the Thioether Moiety
| S-EPMC9344801 | biostudies-literature
Unknown 2-Methyl-1,2,4-triazolo[4,3-a]pyridin-2-ium tetra-fluoroborate.
| S-EPMC3772483 | biostudies-literature